Effects of Intracoronary Tissue-Type Plasminogen Activator Treatment in Kawasaki Disease and Acute Myocardial Infarction

Publisher： Karger

E-ISSN： 1421-9751|94|1|52-57

ISSN： 0008-6312

Source： Cardiology, Vol.94, Iss.1, 2000-11, pp. : 52-57

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plasma Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Acute Myocardial Infarction

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 2, 2002-07 ,pp. : 80-84

Karger

Access to resources Recommend Favorite

Thrombolytic Therapy with Streptokinase and Tissue Plasminogen Activator in a Patient with Suspected Acute Myocardial Infarction: A Decision Analysis

By  

Cardiology, Vol. 91, Iss. 4, 1999-10 ,pp. : 243-249

Karger

Access to resources Recommend Favorite

Microvascular Effect of Intracoronary Eptifibatide in Acute Myocardial Infarction

By  

Cardiology, Vol. 123, Iss. 1, 2012-09 ,pp. : 46-53

Karger

Access to resources Recommend Favorite

Effects of the Magenstrasse and Mill Operation for Obesity on Plasma Plasminogen Activator Inhibitor Type 1, Tissue Plasminogen Activator, Fibrinogen and Insulin

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 40-43

Karger

Access to resources Recommend Favorite

A synthetic peptide derived from staphylokinase enhances plasminogen activation by tissue‐type plasminogen activator

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 9, Iss. 5, 2011-05 ,pp. : 997-1006

John Wiley & Sons Inc

Access to resources Recommend Favorite